We conclude that median time-to-death is especially prolonged among ER-positive and low-risk ER-negative cancers, and the mean duration of tumour dormancy can be predicted by tumour factors such as grade, tumour size, nodal status and PR status. This evidence concerns the gene PGR and cancer.